PRESERVIKAL HUDUDNING O'SMALARI BO'LGAN AYOLLARNING QON ZARDOBIDAGI IMMUNOGLOBULIN TARKIBINI O'RGANISHNING QIYOSIY NATIJALARI
##article.subject##:
immunoglobulin, gumoral immunitet, biologik marker, gumoral omil, plazma hujayralari##article.abstract##
Tadqiqotda bachadon bo'yni saratonidan oldingi lezyonlari bo'lgan ayollarda sarum immunoglobulinlaridagi o'zgarishlar o'rganildi. Ayollarda bachadon bo'yni saratoni og'ir kurs, past davolash samaradorligi bilan tavsiflanadi va ko'pincha o'limga olib keladi. Bachadon bo'yni saratonidan oldingi shikastlanishlar ushbu tibbiy va ijtimoiy-iqtisodiy muammoning asosiy xavf omillaridan biri ekanligi isbotlangan. Shuning uchun bu kasallikni aniq aniqlash uchun biologik belgilar va klinik laboratoriya mezonlarining mavjudligi juda muhimdir. Yuqoridagilarni hisobga olgan holda, tadqiqotning maqsadi bachadon bo'yni prekanseroz kasalliklari bo'lgan ayollarning qon zardobidagi gumoral immunitet omillarining kontsentratsiyasini qiyosiy o'rganish edi.
Библиографические ссылки
Gizinger O.A. Immunomodulation in gynecology. Opinions of an immunologist and an obstetrician-gynecologist. Practical questions of colposcopy // Genital Infections. – 2022. – No.2. – P.18-23.
Abakumova T.V., Myagdieva I.R., Dolgova D.R., Gening S.O., Antoneyeva I.I., Gening T.P. IL-4 and its polymorphism (IL4-589C/T) in cervical neoplasia // Medical Immunology. – 2023. – Vol.25, No.5. – P.1129-1134.
Belyavskaya V.A., Cherdyntseva N.V., Kzyszkovska Yu.G., Litvyakov N.V. Microbiome, immune system and cancer: three sides of the same medal // Siberian Oncological Journal. – 2022. – No.21(6). – P.131-144.
Ikhtiyarova G.A., Navruzova N.O., Karimova G.K. Modern diagnostic methods for early detection of cervical diseases // Doktor Axborotnomasi. – 2019. – No.4. – P.78-80.
Mazitova M.I., Bikineev M.S. Stages of cytological screening for cervical cancer // R.M.J. Mother and Child. – 2019. – Vol.2, No.4. – P.322-326.
Loginova O.P., Shevchenko N.I., Gasich E.L. Peculiarities of local vaginal immunity in HPV-negative cervical dysplasia // Medical-Biological Science News. – 2025. – Vol.25, No.3. – P.230-239.
Mamedov U.S., Mirakhmedova S.S. Dynamics of women’s immune status during cervical HPV treatment // Bulletin of Science and Education. – 2020. – No.24(102), Pt.3. – P.81-84.
Semiglazov V.F., Tseluyko A.I., Balduyeva I.A., Nekhaeva T.L., Artemieva A.S., Kudaybergenova A.G. et al. Immunology and immunotherapy in combined treatment of malignant tumors // Medical Council. – 2021. – No.4. – P.248-257.
Petrov Yu.A., Blesmanovich A.E., Bagnovskaya A.G. From background processes to cervical cancer: causes, diagnosis, and prevention // Glavvrach of South Russia. – 2020. – Vol.74, No.4. – P.36-39.
Zhen S., Lu J., Liu Y.-H., Chen W., Li X. Synergistic antitumor effect on cervical cancer by rational combination of PD-1 blockade and CRISPR-Cas9-mediated HPV knockout // Cancer Gene Therapy. – 2019. – Vol.27. – P.168-178.
